Kura Oncology (KURA) Announces Presentation of Encouraging Preclinical Data on KO-947
Tweet Send to a Friend
Kura Oncology, Inc. (Nasdaq: KURA) presented preclinical data highlighting the identification and characterization of KO-947, its development candidate targeting ERK1/2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
